As the Nasdaq Composite hits record highs and the Dow Jones Industrial Average experiences its eighth consecutive day of decline, investors are closely watching market movements ahead of the ...

After hours: December 27 at 4:20:00 PM EST Loading Chart for PRVA ...

Macquarie initiated coverage of Privia Health (PRVA) with an Outperform rating and $25 price target Privia is an enduring leader aiding the transformation of the trillion-dollar healthcare ...

Here are the year’s notable fiction, poetry and nonfiction, chosen by the staff of The New York Times Book Review. The winner of this year’s National Book Award in fiction has published ...

Join former prosecutor Andy McCarthy as he delves into the legal ins and outs of the latest Washington dramas with National Review editor in chief Rich Lowry. Capital Record – your weekly ...

Suggested reading from critics and editors at The New York Times. Novels by Adam Ross, Han Kang and Nnedi Okorafor; nonfiction by Imani Perry and the “Hipster Grifter”; and more. Elaborately ...

In this guide we show you how to make the best of long winter nights with some night time photography.

Through its G-Shock line, Casio has built a reputation as a maker of some of the toughest watches in the world. G-Shocks are built to withstand myriad extreme outdoor environments, but there’s one ...

Analyst Price Forecast Suggests 24.09% Upside As of December 3, 2024, the average one-year price target for Privia Health Group is $27.15/share. The forecasts range from a low of $21.21 to a high ...